Immunic Balance Sheet Health
Financial Health criteria checks 4/6
Immunic has a total shareholder equity of $41.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $64.8M and $23.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$59.07m |
| Equity | US$41.22m |
| Total liabilities | US$23.54m |
| Total assets | US$64.76m |
Recent financial health updates
We're Keeping An Eye On Immunic's (NASDAQ:IMUX) Cash Burn Rate
Oct 25
Here's Why We're A Bit Worried About Immunic's (NASDAQ:IMUX) Cash Burn Situation
Jan 22Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely
Oct 13Will Immunic (NASDAQ:IMUX) Spend Its Cash Wisely?
Jun 27Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely
Jul 27Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?
Apr 13Recent updates
We're Keeping An Eye On Immunic's (NASDAQ:IMUX) Cash Burn Rate
Oct 25Here's Why We're A Bit Worried About Immunic's (NASDAQ:IMUX) Cash Burn Situation
Jan 22Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely
Oct 13Will Immunic (NASDAQ:IMUX) Spend Its Cash Wisely?
Jun 27Immunic sinks ~74% after hours as phase 1b psoriasis trial fails to separate from placebo
Oct 20Immunic stock gains on $60M oversubscribed PIPE financing
Oct 10Immunic GAAP EPS of -$0.72 in-line
Aug 04Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely
Jul 27Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?
Apr 13Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?
Dec 24Here's Why We're Watching Immunic's (NASDAQ:IMUX) Cash Burn Situation
Aug 13We're Hopeful That Immunic (NASDAQ:IMUX) Will Use Its Cash Wisely
May 10Immunic EPS misses by $0.95
May 06Immunic EPS misses by $0.07
Nov 05Enrollment underway in Immunic's Phase 2 part of IMU-838 study in COVID-19
Nov 02Immunic (IMUX) Investor Presentation - Slideshow
Oct 31Financial Position Analysis
Short Term Liabilities: IMUX's short term assets ($63.3M) exceed its short term liabilities ($23.4M).
Long Term Liabilities: IMUX's short term assets ($63.3M) exceed its long term liabilities ($186.0K).
Debt to Equity History and Analysis
Debt Level: IMUX is debt free.
Reducing Debt: IMUX has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IMUX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: IMUX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 22.3% each year